The Fund aims to achieve a high level of monthly income with prospects for capital growth.
Name | % Net Assets |
---|---|
GlaxoSmithKline PLC | 6.8% |
Royal Dutch Shell PLC (CL B) | 6.5% |
Vodafone Group PLC | 6.0% |
British American Tobacco PLC | 4.8% |
BT Group PLC | 3.2% |
BP PLC | 3.1% |
BG Group PLC | 2.9% |
Imperial Tobacco Group PLC | 2.8% |
Legal & General Group PLC | 2.7% |
HSBC Holdings PLC | 2.2% |
Key | % Net Assets |
---|---|
GlaxoSmithKline PLC | 6.8% |
Royal Dutch Shell PLC (CL B) | 6.5% |
Vodafone Group PLC | 6.0% |
British American Tobacco PLC | 4.8% |
Other | 75.9% |
Date | 13-Nov-2024 |
---|---|
NAV | 70.83p |
Currency | GBP |
Change | -0.36p |
% | -0.51% |
YTD change | 1.55p |
YTD % | 2.24% |
Fund Inception | 01/01/1964 |
---|---|
Fund Manager | Jonathan Barber |
TER | 1.61 (30-Mar-2012) |
Minimum Investment | |
---|---|
Initial | £2000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 3.75% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.12 |
You are here: research